Tag Archives: Biotechnology

Your own stem cells can help treat heart disease

Transplanting own stem cells into heart of severe angina patients lessens their pain and improves their ability to walk, a new study has revealed.

The largest national stem cell study for heart disease showed that transplant subjects also experienced fewer deaths than those who didn’t receive stem cells.

In the 12-month Phase II, double-blind trial, subjects’ own purified stem cells, called CD34+ cells, were injected into their hearts in an effort to spur the growth of small blood vessels that make up the microcirculation of the heart muscle (…)

He also said that this study provides the first evidence that a person’s
Read More…

SWITZERLAND – Investments in Stem Cell Research

Image via Wikipedia

Halfway through February, the National Swiss Fund has established a national plan for stem cell research and regenerative medicine, providing 10 million francs (6,766,000 euros) in financing over 5 years. In November, the Foundation will make a decision on projects that have already been submitted. In January 2010, those which have been approved will get underway. The objective is to favor basic biological stem cell and regenerative medicine research, and to spread awareness internationally.

At the end of 2004 in a referendum, Swiss citizens approved a law that allows the use of excess embryonic
Read More…

Sperm From Stem Cells

(CBS) This week, British researchers announced another extraordinary breakthrough in medical research. They have taken stem cells from an embryo and created human sperm.

It’s very exciting, said the man who led the team. They have heads, they have tails, and they move. They have all the essential qualities for creating life. The aim, we are told, is to revolutionize the treatment of infertility.

But this discovery has created some interesting dilemmas. Sperm could be produced from female stem cells. That would mean women would no longer need men to create babies. It could also be theoretically used to produce
Read More…

Excellent Stem Cell Mobilization and Safety Profile for TG-0054

TaiGen Biotechnology Co., Ltd. announced today that in a phase 1 study in healthy volunteers TG-0054, a chemokine receptor CXCR4 antagonist, was well tolerated and rapidly mobilized stem cells and endothelial progenitor cells from bone marrow into peripheral blood. The number of CD34+ stem cells in circulation after one dose of TG-0054 was equal or higher than reported cell numbers needed for stem cell transplantation in cancer patients. The observed AEs were all mild and transient. A phase 2 study in stem cell transplantation for multiple myeloma, non-Hodgkin lymphoma and Hodgkin disease patients is currently being initiated (…)

“We are
Read More…

New clinical trial tests efficacy of stem-cell therapy for stroke

An emergency helicopter trip in May that brought a stroke patient from Forrest General Hospital in Hattiesburg landed the Clarke County resident the first spot in a clinical trial at the University of Mississippi Medical Center for stem-cell therapy.

The new therapy could prevent further brain injury following the initial stroke, preserve vital motor and cognitive abilities and shorten recovery times.

The stem-cell treatment also could add a full day to a narrow four-and-a-half-hour window when current drug treatments work best.
The UMMC Comprehensive Stroke Center is one of 10 U.S. sites enrolling a total of 120 patients into the study. The
Read More…